Glaxosmithkline Shewalton Road Solar PV Park is a 20MW solar PV power project. It is planned in Scotland, the UK. The project is currently in permitting stage. It will be developed in single phase. Post completion of the construction, the project is expected to get commissioned in 2022.
|Project Type||Total Capacity (MW)||Active Capacity (MW)||Pipeline Capacity (MW)||Project Status||Project Location||Project Developer||Solar PV||20||–||20||Permitting||Scotland, the UK||The Farm Energy|
The project is being developed and currently owned by The Farm Energy.
Glaxosmithkline Shewalton Road Solar PV Park is a ground-mounted solar project which is planned over 23 hectares.
The project cost is expected to be around $18.3m.
The solar power project consists of 45,000 modules.
Post completion of the construction, the project is expected to get commissioned in 2022.
Power Purchase Agreement
The power generated from the project will be sold to GlaxoSmithKline under a power purchase agreement for a period of 20 years.
All power projects included in this report are drawn from GlobalData’s Power Intelligence Center. The information regarding the project parameters is sourced through secondary information sources such as electric utilities, equipment manufacturers, developers, project proponent’s – news, deals and financial reporting, regulatory body, associations, government planning reports and publications. Wherever needed the information is further validated through primary from various stakeholders across the power value chain and professionals from leading players within the power sector.